Study reveals that COVID-19 vaccines moderately reduce the risk of long COVID in children, with higher effectiveness observed in adolescents compared to younger children.
Injectable Anticoagulant Substantially Cuts Bleeding Risk in Afib
Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of